| Mar'19 | Mar'18 | Mar'17 | ||||
|---|---|---|---|---|---|---|
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||
305,076 | 291,622 | 110,631 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation, depletion, and amortization | ||||||
225,921 | 178,332 | 188,142 | ||||
Deferred income taxes | ||||||
-6,511 | -24,722 | 31,274 | ||||
Share-based compensation | ||||||
23,965 | 22,187 | 18,794 | ||||
(Gain) loss on the disposal of property, plant, and equipment, and intangibles, net | ||||||
-924 | -2,582 | -760 | ||||
Gain (Loss) on Disposition of Business | ||||||
1,370 | -14,547 | -86,574 | ||||
Goodwill, Impairment Loss | ||||||
0 | 0 | 58,356 | ||||
Other items | ||||||
18,397 | -32,229 | 13,242 | ||||
Changes in operating assets and liabilities, net of effects of acquisitions: | ||||||
Accounts receivable, net | ||||||
48,486 | 37,731 | 48,140 | ||||
Inventories, net | ||||||
14,617 | 5,178 | 12,829 | ||||
Other current assets | ||||||
7,371 | 1,244 | -2,324 | ||||
Accounts payable | ||||||
21,244 | 563 | 6,884 | ||||
Accruals and other, net | ||||||
59,127 | -15,555 | -5,442 | ||||
Net cash provided by operating activities | ||||||
539,505 | 457,632 | 424,086 | ||||
Investing activities: | ||||||
Purchases of property, plant, equipment, and intangibles, net | ||||||
189,715 | 165,457 | 172,901 | ||||
Proceeds from the sale of property, plant, equipment, and intangibles | ||||||
5,567 | 2,094 | 4,846 | ||||
Proceeds from Divestiture of Businesses | ||||||
2,478 | 8,888 | 135,713 | ||||
Purchase of investments | ||||||
4,955 | 0 | 6,356 | ||||
Acquisition of businesses, net of cash acquired | ||||||
13,313 | 46,271 | 65,557 | ||||
Payments for (Proceeds from) Other Investing Activities | ||||||
13,286 | 3,083 | 0 | ||||
Net cash used in investing activities | ||||||
-213,224 | -203,829 | -104,255 | ||||
Financing activities: | ||||||
Proceeds from Issuance of Private Placement | ||||||
0 | 0 | 293,730 | ||||
Payments on long-term obligations | ||||||
85,000 | 222,500 | 172,500 | ||||
Proceeds (Payments) under credit facilities, net | ||||||
-27,087 | 29,065 | -196,613 | ||||
Deferred financing fees and debt issuance costs | ||||||
488 | 2,029 | 1,073 | ||||
Acquisition related deferred or contingent consideration | ||||||
1,327 | 2,064 | 9,918 | ||||
Repurchases of ordinary shares | ||||||
81,494 | 65,485 | 97,509 | ||||
Cash dividends paid to ordinary shareholders | ||||||
112,503 | 102,929 | 93,193 | ||||
Proceeds from issuance of equity to minority shareholders | ||||||
0 | 0 | 5,022 | ||||
Stock option and other equity transactions, net | ||||||
13,107 | 9,758 | 4,955 | ||||
Net cash used in financing activities | ||||||
-294,792 | -356,184 | -267,099 | ||||
Effect of exchange rate changes on cash and cash equivalents | ||||||
-12,390 | 20,997 | -18,655 | ||||
Increase (decrease) in cash and cash equivalents | ||||||
19,099 | -81,384 | 34,077 | ||||